Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Keenova Therapeutics plc | 506,815 | reported | 25 Feb 2026 | tx 17+1,389,134−1,083,616 |
| Actavis plc | 71,947 | reported | 11 Nov 2013 | tx 2+96,947−25,000 |
| Pfenex Inc. | 18,000 | reported | 09 May 2019 | tx 3+61,000 |
| WATSON PHARMACEUTICALS INC | 0 | reported | 01 Oct 2013 | tx 19+437,805−442,305 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Feb 2026 | GRANT_AWARD | Keenova Therapeutics plc | 198,539 | 0.00 USD | deriv |
| 01 Jan 2026 | EXERCISE | Keenova Therapeutics plc | 32,878 | — | |
| 01 Jan 2026 | TAX_WITHHOLDING | Keenova Therapeutics plc | 16,939 | — | |
| 01 Jan 2026 | EXERCISE | Keenova Therapeutics plc | 32,878 | 0.00 USD | deriv |
| 14 Aug 2025 | GRANT_AWARD | Keenova Therapeutics plc | 65,005 | 0.00 USD | deriv |
| 31 Jul 2025 | GRANT_AWARD | Keenova Therapeutics plc | 164,137 | 0.00 USD | deriv |
| 01 Jan 2025 | EXERCISE | Keenova Therapeutics plc | 27,355 | — | |
| 01 Jan 2025 | TAX_WITHHOLDING | Keenova Therapeutics plc | 11,580 | — | |
| 01 Jan 2025 | EXERCISE | Keenova Therapeutics plc | 27,355 | 0.00 USD | deriv |
| 02 Feb 2024 | GRANT_AWARD | Keenova Therapeutics plc | 82,068 | 0.00 USD | deriv |
| 14 Nov 2023 | OTHER | Keenova Therapeutics plc | 189,863 | 0.00 USD | |
| 14 Nov 2023 | OTHER | Keenova Therapeutics plc | 672,948 | 0.00 USD | deriv |
| 23 Jun 2023 | TAX_WITHHOLDING | Keenova Therapeutics plc | 38,409 | 1.31 USD | |
| 03 Apr 2023 | GRANT_AWARD | Keenova Therapeutics plc | 672,948 | 0.00 USD | deriv |
| 13 Mar 2023 | PURCHASE | Keenova Therapeutics plc | 3,000 | 8.37 USD | |
| 14 Dec 2022 | GRANT_AWARD | Keenova Therapeutics plc | 225,272 | 0.00 USD | |
| 09 May 2019 | GRANT_AWARD | Pfenex Inc. | 18,000 | 0.00 USD | deriv |
| 09 May 2018 | GRANT_AWARD | Pfenex Inc. | 18,000 | 0.00 USD | deriv |
| 05 May 2017 | GRANT_AWARD | Pfenex Inc. | 25,000 | 0.00 USD | deriv |
| 11 Nov 2013 | SALE | Actavis plc | 25,000 | 159.87 USD | |
| 01 Oct 2013 | GRANT_AWARD | Actavis plc | 96,947 | — | |
| 01 Oct 2013 | OTHER | WATSON PHARMACEUTICALS INC | 96,947 | — | |
| 30 Sept 2013 | GRANT_AWARD | WATSON PHARMACEUTICALS INC | 44,149 | — | |
| 30 Sept 2013 | EXERCISE | WATSON PHARMACEUTICALS INC | 150,000 | 86.86 USD | |
| 30 Sept 2013 | TAX_WITHHOLDING | WATSON PHARMACEUTICALS INC | 181,845 | 144.00 USD |